BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2958195)

  • 41. T-cell-mediated cytotoxicity against Mycobacterium antigen-pulsed autologous macrophages in leprosy patients.
    Sasiain MC; de la Barrera S; Minnucci F; Valdez R; de Elizalde de Bracco MM; BaliƱa LM
    Infect Immun; 1992 Aug; 60(8):3389-95. PubMed ID: 1639507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The recombinant 65-kD heat shock protein of Mycobacterium bovis Bacillus Calmette-Guerin/M. tuberculosis is a target molecule for CD4+ cytotoxic T lymphocytes that lyse human monocytes.
    Ottenhoff TH; Ab BK; Van Embden JD; Thole JE; Kiessling R
    J Exp Med; 1988 Nov; 168(5):1947-52. PubMed ID: 2903217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-major histocompatibility complex-restricted cytotoxic activity of blood mononuclear cells stimulated with secreted mycobacterial proteins and other mycobacterial antigens.
    Ravn P; Pedersen BK
    Infect Immun; 1994 Dec; 62(12):5305-11. PubMed ID: 7960109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro.
    Aguirre-Blanco AM; Lukey PT; Cliff JM; Dockrell HM
    Infect Immun; 2007 Jun; 75(6):3197-201. PubMed ID: 17387167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dendritic cells efficiently immunoselect mycobacterial-reactive T cells in human blood, including clonable antigen-reactive precursors.
    Pancholi P; Steinman RM; Bhardwaj N
    Immunology; 1992 Jun; 76(2):217-24. PubMed ID: 1378816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The restoration of suppressed T cell activities induced by 7,12-dimethylbenz[a]anthracene with an anti-tumor immunomodulator, BCG-cell wall skeleton.
    Yamashita U; Ikegami R; Hamaoka T
    Gan; 1982 Oct; 73(5):783-9. PubMed ID: 6219910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BCG in cancer and leukemia treatment and prophylaxis-A review.
    Rosenthal SR
    J Med; 1975; 6(3-4):193-212. PubMed ID: 1104732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids.
    Fournie JJ; Adams E; Mullins RJ; Basten A
    Infect Immun; 1989 Nov; 57(11):3653-9. PubMed ID: 2572559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytolytic T-cell responses to human dendritic cells and macrophages infected with Mycobacterium bovis BCG and recombinant BCG secreting listeriolysin.
    Conradt P; Hess J; Kaufmann SH
    Microbes Infect; 1999 Aug; 1(10):753-64. PubMed ID: 10816080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mycobacterial crossreactivity of M. tuberculosis reactive T cell clones from naturally converted PPD positive healthy subjects.
    Oftung F; Borka E; Kvalheim G; Mustafa AS
    FEMS Immunol Med Microbiol; 1998 Mar; 20(3):231-8. PubMed ID: 9566494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell-mediated immunity.
    Goust JM
    Immunol Ser; 1990; 50():195-215. PubMed ID: 2151118
    [No Abstract]   [Full Text] [Related]  

  • 52. [Action of hydrocortisone on the cytotoxic reactions in delayed hypersensitivity to microbial antigens].
    Bazanova EA; Smirnova MN; Liampert IM
    Biull Eksp Biol Med; 1985 Jun; 99(6):723-5. PubMed ID: 2410059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soluble CD4 suppress the antigen driven proliferative response of certain T cell clones specific for mycobacteria and for peptides by mycobacterial heat shock proteins.
    Gidlund M; Halapi E; Cornelisse Y; Ottenhof T; Wigzell H; Kiessling R
    Int Immunol; 1992 Mar; 4(3):355-60. PubMed ID: 1567792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD4+ cytolytic T cells can destroy autologous and MHC-matched macrophages but fail to kill intracellular Mycobacterium bovis-BCG.
    Pithie AD; Lammas DA; Fazal N; Rahelu M; Bartlett R; Gaston JS; Kumararatne DS
    FEMS Immunol Med Microbiol; 1995 Apr; 11(2):145-54. PubMed ID: 7543788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antigen presentation of human B lymphocytes on BCG particulate antigen].
    Yin TG; Wu HJ
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Dec; 20(4):377-80. PubMed ID: 2630415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppressor versus cytolytic CD8+ T lymphocytes: where are the artefacts?
    Pereira P; Larsson-Sciard EL; Coutinho A; Bandeira A
    Scand J Immunol; 1988 Jun; 27(6):625-8. PubMed ID: 2969138
    [No Abstract]   [Full Text] [Related]  

  • 57. BCG-induced chronic pulmonary inflammation and splenomegaly in mice: suppression of PHA-induced proliferation, delayed hypersensitivity to sheep erythrocytes, and chronic pulmonary inflammation by soluble factors from adherent spleen cells.
    Allen EM; Sternick JL; Schrier DJ; Moore VL
    Cell Immunol; 1981 Feb; 58(1):61-71. PubMed ID: 6452952
    [No Abstract]   [Full Text] [Related]  

  • 58. Soluble factors from BCG-induced suppressor cells inhibit in vitro PFC responses but not cytotoxic responses.
    Klimpel GR
    Cell Immunol; 1979 Sep; 47(1):218-26. PubMed ID: 159779
    [No Abstract]   [Full Text] [Related]  

  • 59. Mycobacterium tuberculosis antigen specific human T-cell lines are cytolytic to autologous antigen pulsed macrophages.
    Kumararatne DS; Drysdale P; Gaston JS; Stacey P; Richardson P; Wise R
    Adv Exp Med Biol; 1988; 237():401-6. PubMed ID: 3151038
    [No Abstract]   [Full Text] [Related]  

  • 60. [Antigenic analysis of the structural components of the surface of BCG cells].
    Shimono T; Kotani S; Kato K; Hirachi Y
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):90. PubMed ID: 765574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.